文献速递炎症性肠病

克罗恩病相关肠壁损伤的治疗:一项系统综述

Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-08-23

该系统综述检索了1960年1月至2017年7月的PubMed、EMBASE和Cochrane数据库,评估克罗恩病肠壁损伤的机制与潜在治疗。损伤机制涉及成纤维细胞增殖迁移、星状细胞活化及基质金属蛋白酶与组织抑制剂失衡;减少转化生长因子β过度激活的药物可能有效,间充质干细胞局部注射在随机对照试验中可愈合肛周瘘管。结论认为需测试减少转化生长因子β的药物并继续研究间充质干细胞局部注射。

要点

  • 克罗恩病肠壁损伤机制包括成纤维细胞增殖迁移、星状细胞活化及细胞转分化。
  • 基质金属蛋白酶与组织抑制剂失衡可能促进瘘管形成。
  • 随机对照试验显示间充质干细胞局部注射可愈合肛周瘘管。

核心结论

  • 作者认为需要测试减少转化生长因子β并促进透壁损伤病灶愈合的药物,并继续研究间充质干细胞的局部注射。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和Cochrane数据库1960年1月至2017年7月的全文文章,并检索会议摘要及手动检索参考文献列表。

主要发现

  • 克罗恩病肠壁损伤机制包括成纤维细胞增殖和迁移、星状细胞活化、肠道或肠外成纤维细胞募集及细胞转分化。
  • 基质金属蛋白酶与组织金属蛋白酶抑制剂平衡改变可能促进瘘管形成。
  • 减少过度转化生长因子β激活的治疗方法可能对已形成的肠壁损伤有效。
  • 干细胞疗法对克罗恩病组织损伤病灶有效,随机对照试验显示间充质干细胞局部注射可愈合肛周瘘管。

关键数值与推荐

  • 减少转化生长因子β过度激活的治疗可能对已形成的肠壁损伤有效。
  • 随机对照试验显示间充质干细胞局部注射可愈合肛周瘘管。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Despite significant advances in the treatment of Crohn's disease (CD), most patients still develop stricturing or penetrating complications that require surgical resections. We performed a systematic review of mechanisms and potential treatments for tissue damage lesions in CD patients. METHODS: We searched the PubMed, MBASE, and Cochrane databases from January 1960 to July 2017 for full-length articles on CD, fibrosis, damage lesions, mesenchymal stem cells, and/or treatment. We also searched published conference abstracts and performed manual searches of all reference lists of relevant articles. RESULTS: Mechanisms of intestinal damage in patients with CD include fibroblast proliferation and migration, activation of stellate cells, recruitment of intestinal or extra-intestinal fibroblast, and cell trans-differentiation. An altered balance of metalloproteinases and tissue inhibitors of metalloproteinases might contribute to fistula formation. Treatment approaches that reduce excessive transforming growth factor beta (TGFB) activation might be effective in treating established intestinal damage. Stem cell therapies have been effective in tissue damage lesions in CD. Particularly, randomized controlled trials have shown local injections of mesenchymal stem cells to heal perianal fistulas. CONCLUSION: In a systematic review of mechanisms and treatments of bowel wall damage in patients with CD, we found a need to test drugs that reduce TGFB and increase healing of transmural damage lesions and to pursue research on local injection of mesenchymal stem cells.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Pariente B, Hu S, Bettenworth D, et al. Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review. Clin Gastroenterol Hepatol. 2018. PMID: 30012430. doi:10.1016/j.cgh.2018.06.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。